Literature DB >> 3032817

Human papillomavirus type 16 in intraepithelial neoplasia (bowenoid papulosis) and coexistent invasive carcinoma of the vulva.

C Bergeron, Z Naghashfar, C Canaan, K Shah, Y Fu, A Ferenczy.   

Abstract

Tissues from two cases of bowenoid papulosis of the vulva with coexistent invasive squamous cell carcinoma were evaluated for the presence of human papillomaviruses (HPVs) and for nuclear DNA content. In both cases, HPV type 16 and nuclear aneuploidy were found in bowenoid papulosis as well as in invasive carcinoma. Patterns of hybridization suggested that the viral genome was integrated into the cellular genome in both bowenoid papulosis tissues as well as in invasive carcinoma tissues. These observations suggest that lesions designated as bowenoid papulosis may have invasive cancer potential. The term vulvar intraepithelial neoplasia seems to be more appropriate for HPV-16-containing aneuploid, intraepithelial lesions of the vulva.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032817     DOI: 10.1097/00004347-198703000-00001

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  Treatment of human papillomavirus-associated vulvar disease with the CO2-laser. Physical and histological aspects with use of a new scanning device, the SwiftLase.

Authors:  S Spörri; M Frenz; H J Altermatt; E V Hannigan; E Dreher
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

2.  Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin.

Authors:  J A Carlson; K Healy; T A Tran; J Malfetano; V L Wilson; A Rohwedder; J S Ross
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

3.  Detection of human papillomavirus type 16 DNA and papillomavirus genus-specific antigens in vulva and cervix from patients with Bowenoid papulosis.

Authors:  M Sugase; S Moriyama; S Hata; T Matsukura
Journal:  Jpn J Cancer Res       Date:  1989-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.